In depth Archives - Page 10 of 15 - El·lipse

Once we have a coronavirus vaccine, will there be people who won't want to get vaccinated? And why? Photo by National Cancer Institute on Unsplash.

Public engagement 10.08.2020

What if… there is a coronavirus vaccine and people don’t want to get vaccinated?

Marga Sala, general manager of the PRBB, is grateful for the resilience and ability to adapt to the new circumstances shown by all the staff during the coronavirus crisis.

Community 04.08.2020

Marga Sala (PRBB): “We went from 2000 to 200 people in the building in two days”

Pulmobiotics is a CRG spin-off that aims to develop therapeutic applications for lung diseases. Photo by Robina Weermeijer on Unsplash.

Scientific life 27.07.2020

Pulmobiotics: transforming a pathogen to fight lung disease

The scientists used the zebrafish embryo with fluorescent sensory neurons. Image by Berta Alsina.

Research 24.07.2020

Blood vessels regulate the proliferation and differentiation of sensory neurons

Scientific life 22.06.2020

How to be a researcher and a mum in times of Covid-19

From left to right, Tomàs Marquès-Bonet and Salvador Carranza, former and new IBE director, respectively.

Community 17.06.2020

Face to face: the outgoing and incoming directors of the IBE reflect on the centre

The speed with which research results about the coronavirus are going from bench to publication is like nothing we've ever seen before. But it has risks.

Scientific life 01.06.2020

The coronavirus that accelerated science like nothing before

Volunteers from the CRG are coming in everyday to the PRBB to run tests on the coronavirus.Volunteers from the CRG are coming in everyday to the PRBB to run tests on the coronavirus.

Community 25.05.2020

“You are never prepared for this” – an opinion article on the COVID-19 testing experience

The last "IMIM Seminars At Home" presented two of the Covid19 projects taking place at the IMIM. One focuses on drug development, the other relies on the immune response.

Research 22.05.2020

Drugs and antibodies: the strategies of two IMIM groups to block SARS-CoV-2

| Edited picture from the National Cancer Institute on Unsplash.

Research 07.04.2020

On Covid-19 research at the PRBB

Miki Ebisuya arrived to the EMBL Barcelona, at the PRBB, in 2018 to lead her group on synthetic developmental biology.

Scientific life 01.04.2020

Miki Ebisuya (EMBL Barcelona): “Research is a privilege; I can spend my life studying what I find interesting”

Research 30.03.2020

Designing inhibitors of tumor evolution to make cancer a chronic disease